Cargando…
Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy
Fabry disease is a lysosomal storage disorder (LSD) caused by deficiency of α-galactosidase A (α-gal A), resulting in deposition of globotriaosylceramide (Gb3; also known as ceramide trihexoside) in the vascular endothelium of many organs. A gradual accumulation of Gb3 leads to cardiovascular, cereb...
Autores principales: | LEE, MI HEE, CHOI, EUN NAM, JEON, YEO JIN, JUNG, SUNG-CHUL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042857/ https://www.ncbi.nlm.nih.gov/pubmed/23007467 http://dx.doi.org/10.3892/ijmm.2012.1139 |
Ejemplares similares
-
Impact of gene polymorphisms of interleukin-18, transforming growth factor-β, and vascular endothelial growth factor on development of IgA nephropathy and thin glomerular basement membrane disease
por: Jung, Hee-Yeon, et al.
Publicado: (2012) -
Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy
por: Lin, Shuhua, et al.
Publicado: (2016) -
Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling
por: Weidenaar, A C, et al.
Publicado: (2011) -
Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010) -
Modulation of Notch-1 Signaling Alleviates Vascular Endothelial Growth Factor–Mediated Diabetic Nephropathy
por: Lin, Chun-Liang, et al.
Publicado: (2010)